CreditsHosts: Devindra Hardawar and Igor Bonifacic
The drug, called orforglipron and manufactured by Eli Lilly, is prescribed for type 2 diabetes and targets the same GLP-1 receptors as oral semaglutide. Like semaglutide, it lowers blood sugar levels, slows digestion and suppresses appetite. Unlike semaglutide tablets, it does not need to be taken on an empty stomach.
，详情可参考搜狗输入法2026
Members get access to community
但有一件事很可能不會被提及：「2025計劃」（Project 2025）。